___

• Hilger WS, Magrina JF, Magtibay PM. Laparoscopic management of the adnexal mass. Clin Obstet Gy- necol 2006;49(3):535–548 .
• Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 1989;74(6):921-6.
• Finkler NJ, Benacerraf B, Lavin PT, et al. Comparasion of serum CA 125, Clinical Impression and Ultrasound in the Preoperative Evalution of Ovarian Mass. Obstet Gynecol 1988;72(4):659-64.
• Jacobs I, Oram D, Fairbanks J, et al. A risk of malig- nancy index incorporating CA-125, ultrasound and menopausal status or the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990;97(10):922- 929.
• Tingulstad S, Hagen B, Skjeldestad F, et al. Evaluation of a risk of malignancy index based on serum CA- 125, ultrasound findings and menopausal status in the pre- operative diagnosis of pelvic masses. Br J Obstet Gy- naecol 1996;103(8):826-31.
• Tingulstad S, Hagen B, Skjeldestad FE, et al. The risk- of-malignancy index to evaluate potential ovarian can- cers in local hospitals. Obstet Gynecol 1999;93(3):448- 52.
• Yamamoto Y, Yamada R, Oguri H, et al. Comparison of four malignancy indices in the preoperative evalu- ation of patients with pelvic masses. Eur J Obs Gyn Reprod Biol 2009;144(2):163-7.
• 8- Kanthikar SN, Dravid NV, Deore PN, et al. Clinico- histopatological analysis of Neoplastic and Non-Ne- oplastic Lesions of the Ovary: A 3-Year Prospective Study Journal of Clinical and Diagnostic Research. 2014;8(8):FC04-FC07.
• Bast RC, Klug TL, St John E, et al. Aradioimmunas- say using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983;309(15):883-7.
• Chou CY, Chang CH, Yao BL, et al. Color doppler ul- trasonography and serum CA125 the differentiation of benign and malignant ovarian tumors. J Clin Ultra- sound 1994;22(8):491-6.
• Niloff JM, Bast RC Jr, Schaetzl EM, Knapp RC. Predic- tive value of CA 125 antigen levels in second-look procedures for ovarian cancer. Am J Obstet Gynecol 1985;151(7):981-6.
• Schutter EM, Kenemans P, Sohn C, et al. Diagnos- tic value of pelvic examination , ultrasound ,and se- rum CA125 in postmenopausal women with a pelvic mass: an international multicenter study. Cancer 1994;74(4):1398-406.
• Medeiros LR, Rosa DD, da Rosa MI, et al. Accuracy of CA-125 in the diagnosis of ovarian tumors: A quantita- tive systematic review. Eur J Obstet Gynecol Reprod Biol 2009;142(2):99-105
• Wang J, Sharma A, Ghamande SA et al. Serum protein profile at remission can accurately assess therapeutic outcomes and survival for serous ovarian cancer. PLoS One 2013;8(11):e78393.
• Bast RC, Xu F, Yu Y, et al. CA125 the past and the fu- ture. Int J Biol Markers 1998;13(4):179-87.
• Kurjak A, Schulman H, Sosic A, et al. Transvaginal ultrasound, color flow and doppler wave form of the postmenopausal adnexal mass. Obstet Gynecol 1992;80(6):917-21.
• Alobaid A, Memon A, Alobaid S, et al. Laparoscopic management of huge ovarian cysts. Int J Gynecol Ob- stet 2013;2013:380854.
• Ou CS, Liu YH, Zabriskie V, et al. Alternate methods for laparoscopic management of adnexal masses greater than 10 cm in diameter. J Laparoendosc Adv Surg Tech 2001;11(3):125-32.
• Salem HA. Laparoscopic excision of large ovarian cysts. J Obstet Gynaecol Res 2002;28(6):290-4.
• Sagiv R, Golan A, Glezerman M. Laparoscopic manage- ment of extremely large ovarian cysts. Obstet Gynecol 2005;105(6):1319-22.
• Kreuzer GF, Parodowski T, Wurche KD, et al. Neoplastic or nonneoplastic ovarian cyst? The role of cytology. Acta Cytol 1995;39(5):882-6.
• Martinez-Onsurbe P, Villaespesa AP, Anquela JMS. As- piration cytology of 147 adnexal cysts with histologic correlation. Acta Cytol. 2001;45(6):941-7.
• Maharyan S. Clinicomorphological study of ovar- ian lesions. Journal of Chitwan Medical College 2013;3(6):17-24.
• Al-Fozan H, Tulandi T. Left lateral predisposition of endometriosis and endometrioma. Obstet Gynecol 2003;101(1):164-6.